Boundless Bio Inc (BOLD): Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi

boundlessbio.com (BOLD) tovar belgisi

Boundless Bio, Inc. (BOLD) tadqiqot markazlari barqaror ishlamoqda va sekvensirlash IT klasterlarini ishlab chiqmoqda. Uzoq muddatli moliyaviy leveraj koeffitsiyenti chidamli kapital tuzilmasini namoyish etadi, bunda 0.00 ko'rsatkichning joriy qiymatidir. Onkoterapiya ekotizimi klinikalarning mijozlarni saqlab qolishini ta'minlash uchun EchoSENS platformasiga asoslangan, ecDNA ga qarshi kurashish bo'yicha noyob patentlar esa sog'liqni saqlash gigantlari bilan strategik sheriklik uchun asos yaratadi.

Boundless Bio Inc. (BOLD): Uzoq muddatli qarzning kapitalga nisbati 29.03.2024dan 28.10.2026gacha

Boundless Bio, Inc. (BOLD) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Boundless Bio Inc.|BOLD - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Boundless Bio, Inc.|BOLD - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Boundless Bio|BOLD - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati boundlessbio.com|BOLD - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Boundless Bio, Inc.|BOLD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati boundlessbio.com|BOLD - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Boundless Bio, Inc.
Kompaniyaning fundamental tahlili:BOLD, Boundless Bio Inc.
Boundless Bio, Inc. brend mahsuloti

Boundless Bio, Inc. (BOLD) ekstraxromosomal DNK tahlili va EchoSENS platformasi orqali saraton bilan kurashuvchi innovatsion ekotizimni ishlab chiqmoqda. Ushbu ko'rsatkich uzoq muddatli kredit majburiyatlarini aksiyadorlarning sof aktiv qiymati bilan solishtiradi. U moliyaviy leveraj darajasini va biofarmatsevtika biznesining rivojlanishi qaysidir darajada qarz kapitaliga bog'liqligini aniqlaydi. Bu investorlarga daromadsiz uzoq davrlar davomida bankrotlik xavfini baholashga yordam beradi. Uzoq muddatli qarzlarning kapitalga nisbati tahlili kompaniyaning umumiy barqarorligini tasdiqlaydi.

Boundless Bio, Inc. raqobatchilari

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group QGEN|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Isis Pharmaceuticals (IONS)|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRSP - Uzoq muddatli qarzning kapitalga nisbati|WGS: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati RARE|Uzoq muddatli majburiyatlarning kapitalga nisbati Beam Tx|SRPT (Sarepta Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati TWST|Uzoq muddatli qarzning o'z kapitaliga nisbati 10x Genomics TXG|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Intellia Therapeutics Inc (NTLA)|STOK - Uzoq muddatli qarzning kapitalga nisbati|BioLife - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|WVE - Uzoq muddatli qarzning o'z kapitaliga nisbati|MAZE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati SION|PRME (Prime Medicine Inc) - Uzoq muddatli majburiyatlarning kapitalga nisbati|TSHA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati QURE|MGTX (MeiraGTx Holdings plc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati regenxbio.com RGNX|Uzoq muddatli qarzning o'z kapitaliga nisbati Solid Biosciences|Uzoq muddatli qarzning kapitalga koeffitsiyenti Ocugen Inc OCGN|PACB - Uzoq muddatli qarzning kapitalga nisbati|BNTC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Design Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|RCKT (rocketpharma.com) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati FDMT (4D Molecular Therapeutics, Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati Lexeo (LXEO)|Korro Bio, Inc. (KRRO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Editas Corp (EDIT)|Uzoq muddatli qarzning kapitalga nisbati SLN|ProQR - Uzoq muddatli qarzdorlikning kapitalga nisbati|Codexis Bio (CDXS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|SGMO - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|NAUT (nautilus.bio) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Metagenomi Therapeutics|DTIL: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Generation Bio Corp|Uzoq muddatli qarzning kapitalga nisbati Exicure, Inc. (XCUR)|Uzoq muddatli qarzning o'z kapitaliga nisbati IMNN (imunon.com)|PHIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Mustang Bio Inc - Uzoq muddatli majburiyatlarning kapitalga nisbati|RNAZ - Uzoq muddatli qarzning o'z kapitaliga nisbati|BNGO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Applied DNA Sciences, Inc.|bluebird bio Inc. (BLUE) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati ImmunoPrecise Antibodies Ltd (IPA)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMGA|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems OMIC|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi regulusrx.com (RGLS)|Uzoq muddatli qarzning kapitalga nisbati SYRS (Syros Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Telesis Bio Inc. TBIO|TCON - Uzoq muddatli qarzning kapitalga nisbati|UBX: Uzoq muddatli qarzning o'z kapitaliga nisbati